Safety and Efficacy of Nivolumab and Imiquimod Combination in Vulvar Squamous Cell Carcinoma Patients

NCT07679841 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Vulvar Squamous Cell Carcinoma

Interventions

DRUG: Imiquimod 5% cream
DRUG: Nivolumab

Sponsor

Centre Leon Berard